Intellimedix Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $2.3M
Latest Deal Amount
  • Investors
  • 3

Intellimedix General Information

Description

Developer of novel technologies and approaches to accelerate the discovery of new treatments for neurological diseases. The company analyzes mutations in human genes to identify the diseases a person might have a propensity to develop and suggest compounds (both existing and new) that may be effective in treating the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Primary Office
  • 171 17th. Street
  • Suite 1525
  • Atlanta, GA 30363
  • United States
+1 (770) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intellimedix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-Feb-2015 $2.3M 00.00 Completed Startup
To view Intellimedix’s complete valuation and funding history, request access »

Intellimedix Executive Team (5)

Name Title Board Seat Contact Info
Jim Richards President & Chief Executive Officer
Jim Jacoby Chairman & Founder
Jeffrey Skolnick Ph.D Chief Scientific Officer
To view Intellimedix’s complete executive team members history, request access »

Intellimedix Board Members (1)

Name Representing Role Since
Jim Jacoby Intellimedix Chairman & Founder 000 0000
To view Intellimedix’s complete board members history, request access »

Intellimedix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intellimedix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Chris Klaus Angel (individual) Minority 000 0000 000000 0
Jim Jacoby Angel (individual) Minority 000 0000 000000 0
NeuroLaunch Accelerator/Incubator Minority 000 0000 000000 0
To view Intellimedix’s complete investors history, request access »